查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018517

超音波凝膠市場：按產品類型、黏度等級、成分、應用和最終用戶分類－2026-2032年全球市場預測

Ultrasound Gels Market by Product Type, Viscosity Level, Ingredient Base, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，超音波凝膠市場價值將達到 1.49 億美元，到 2026 年將成長到 1.602 億美元，到 2032 年將達到 2.2046 億美元，複合年成長率為 5.75%。

主要市場統計數據
基準年 2025 1.49億美元
預計年份：2026年 1.602億美元
預測年份 2032 2.2046億美元
複合年成長率 (%) 5.75%

對超音波凝膠產業現況進行詳細概述，重點在於配方、臨床整合、供應鏈韌性和監管關注。

受診斷成像技術進步、臨床工作流程演變以及對感染控制日益成長的關注等因素的推動，全球超音波凝膠市場持續發展。超音波凝膠作為換能器與組織之間至關重要但又常被忽視的接觸點，其配方、黏度和無菌性直接影響影像品質、患者舒適度和檢查效率。隨著診斷和治療性超音波在臨床、門診和獸醫診所等領域的廣泛應用，市場需求也不斷調整以適應新的使用模式和採購重點。

重大的結構性變化正在重塑臨床和獸醫超音波應用領域的產品創新、無菌控制和採購偏好。

超音波凝膠市場正經歷著變革性的轉變，這主要得益於技術和監管重點的融合以及終端用戶期望的提高。配備高頻換能器的成像系統和攜帶式床邊檢測設備的出現，提高了凝膠的性能標準，並刺激了黏度調節和成分選擇的創新，以最佳化聲音耦合。同時，對感染控制和一次性使用設備的需求，也使得人們對無菌配方和分裝方式的關注度不斷提升，這些產品能夠最大限度地降低交叉感染的風險，並支持更有效率的臨床工作流程。

評估2025年美國關稅對原料和供應鏈結構的影響：驅動採購和在地化調整的因素

美國關稅政策將於2025年生效，這將進一步增加依賴跨境供應鏈獲取原料和成品凝膠產品的製造商、經銷商和醫療保健系統的複雜性。對某些聚合物添加劑、界面活性劑和包裝組件徵收關稅，加劇了投入成本的壓力，並促使各方重新談判合約。為此，供應鏈相關人員正加緊努力實現在地化採購、調整安全庫存並重新評估供應商選擇流程，以因應未來政策變革帶來的影響。

透過詳細的細分分析來推動有針對性的產品策略，揭示產品類型、黏度、成分基礎、應用和最終用戶趨勢。

細分市場分析揭示了每個配方和應用類別的清晰性能和應用模式，這些模式決定了產品策略和商業化優先事項。從產品類型來看，非無菌凝膠在常規診斷影像檢查領域仍佔據主導地位，因為成本和易用性至關重要；而對於介入手術、手術全期以及任何因使用侵入性醫療設備或皮膚損傷而導致感染風險較高的情況，對無菌凝膠的需求正在不斷成長。根據黏度水平，高黏度配方因其對垂直表面的黏附性和適用於長時間操作而更受歡迎；中黏度配方為一般診斷應用提供了一種平衡的解決方案；而低黏度凝膠則適用於需要快速探頭移動或特定聲耦合特性的應用。

美洲、歐洲、中東和非洲以及亞太地區的區域商業性和監管趨勢影響著採購、合規和分銷策略。

區域趨勢正在影響三大主要地區的採購方式、監管合規性和商業化策略。在美洲，龐大且多元化的醫院和門診診所網路影響著需求模式，這些機構優先考慮無菌標準、成本控制以及快速採用即時檢驗 (POC) 創新技術。同時，採購框架傾向於採用整合供應商合約和基於價值的採購模式。在歐洲、中東和非洲，複雜的監管環境和多樣化的報銷機制導致不同市場的採納曲線各不相同。雖然某些市場強調成分透明度、永續性和遵守特定地區的醫療設備指令，但該地區的新興市場為具有競爭力的製造商提供了成長機會。

概述策略競爭格局，重點在於全產業的配方差異化、無菌檢驗、包裝創新和夥伴關係機會。

超音波凝膠產業的競爭格局由成熟的製造商、特種化學品公司以及為臨床採購商和經銷商提供自有品牌解決方案的契約製造製造商組成。業界主要企業優先考慮配方差異化、無菌檢驗方案以及包裝創新，以改善一次性產品的處理並降低污染風險。與影像設備製造商 (OEM) 合作推出聯名耗材以及與無菌手術包整合，正成為確保持續需求並加強與銷售管道關係的重要策略途徑。

切實可行的策略建議，重點在於擴大無菌生產能力、模組化產品組合、多元化供應鏈以及夥伴關係主導的商業化。

產業領導企業應採取協作方式，將配方創新、法規準備和供應鏈韌性結合，以保持競爭優勢。首先，應優先投資於無菌配方能力和經驗證的包裝，以支持介入治療和手術全期應用，從而滿足日益成長的感染預防要求，並拓展至更高附加價值的臨床領域。其次，應開發模組化產品系列，涵蓋高、中、低黏度選項，並利用多種原料，以滿足不同的臨床偏好，同時提升生產柔軟性。

採用嚴謹的混合調查方法，結合相關人員訪談、監管審查、第二手資料整合和品質保證檢查。

本研究採用綜合分析方法，透過結構化的研究方法結合一手和二手訊息，確保了穩健且令人信服的證據基礎。一手資訊包括對臨床採購經理、影像科室經理、藥物科學家和供應鏈主管的訪談，揭示了當前的優先事項、挑戰和營運限制。除了這些一線觀點外，本研究還回顧了監管指南、生物相容性和無菌標準，以及關於超音波影像成像和應用案例的最新臨床文獻。

結論強調需要製定整合策略。

總之，超音波凝膠產業正處於一個轉折點，配方科學、監管要求和供應鏈設計在此交匯融合，重新定義了競爭優勢。投資於無菌生產能力、豐富黏度和成分產品線、並增強區域供應韌性的製造商，將更有能力滿足不斷變化的臨床需求和採購需求。同時，醫療系統和經銷商也將受益於與供應商的夥伴關係，這些供應商能夠提供透明的品質文件、可靠的物流以及針對臨床實踐和介入流程量身定做的產品系列。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：超音波凝膠市場：依產品類型分類

  • 非無菌凝膠
  • 消毒凝膠

第9章：超音波凝膠市場

  • 高黏度
  • 低黏度
  • 中等黏度

第10章：超音波凝膠市場

  • 酒精凝膠
  • 蘆薈凝膠
  • 水基凝膠

第11章：超音波凝膠市場：依應用領域分類

  • 醫學診斷
  • 治療性超音波
  • 獸醫應用

第12章：超音波凝膠市場：依最終用戶分類

  • 診所
  • 診斷影像中心
  • 醫院
  • 研究和學術機構

第13章：超音波凝膠市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：超音波凝膠市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：超音波凝膠市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國超音波凝膠市場

第17章：中國超音波凝膠市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AiM Medical Technologies, LLC
  • Aquasonic Ultrasound Gels Inc.
  • Cardinal Health, Inc.
  • Ceracarta SpA
  • Compass Health Brands
  • EDM Medical Solutions
  • General Electric Company
  • HR Pharmaceuticals, Inc.
  • Jorgensen Laboratories, LLC
  • Medline Industries, Inc.
  • NEXT Medical Products Company
  • NIHON KOHDEN CORPORATION
  • PW Coole & Son Ltd Trading
  • Parker Laboratories Inc.
  • Phyto Performance Italia srl
  • Rohde Produits
  • Safersonic
  • Steroplast Healthcare Limited
  • Telic Group
  • Trivitron Healthcare Pvt. Ltd
  • Turkuaz Health
Product Code: MRR-A339DAEFA8F9

The Ultrasound Gels Market was valued at USD 149.00 million in 2025 and is projected to grow to USD 160.20 million in 2026, with a CAGR of 5.75%, reaching USD 220.46 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 149.00 million
Estimated Year [2026] USD 160.20 million
Forecast Year [2032] USD 220.46 million
CAGR (%) 5.75%

A nuanced introduction to the ultrasound gels industry landscape highlighting formulation, clinical integration, supply chain resilience, and regulatory attention

The global ultrasound gels landscape is evolving amid technological advances in imaging modalities, shifting clinical workflows, and heightened attention to infection prevention practices. Ultrasound gel functions as a critical, yet often overlooked, interface between transducers and tissue, and its formulation, viscosity, and sterility properties directly influence image quality, patient comfort, and procedural efficiency. As diagnostic and therapeutic ultrasound expand across point-of-care settings, outpatient clinics, and veterinary practices, demand patterns are adapting to new usage profiles and procurement priorities.

In addition, regulatory scrutiny around product labeling, biocompatibility, and sterility validation has intensified, prompting manufacturers to revisit ingredients and manufacturing controls. Supply chain resilience has emerged as a core operational priority following recent geopolitical disruptions and raw material fluctuations, driving buyers to evaluate supplier diversification, inventory strategies, and regional sourcing options. Taken together, these trends set the stage for a report that examines product differentiation, clinical adoption dynamics, and strategic responses by manufacturers and health systems, with an emphasis on actionable insights for stakeholders seeking to align product portfolios with evolving clinical needs.

Major structural shifts reshaping product innovation, sterility practices, and procurement preferences across clinical and veterinary ultrasound applications

The ultrasound gels sector is experiencing transformative shifts driven by convergence across technology, regulatory focus, and end-user expectations. Imaging systems with higher-frequency transducers and portable point-of-care devices are raising performance thresholds for gels, catalyzing innovation in viscosity modulation and ingredient selection to optimize acoustic coupling. Meanwhile, infection prevention imperatives and single-use device strategies are accelerating interest in sterile formulations and dispensing formats that minimize cross-contamination risk and support streamlined clinical workflows.

Concurrently, sustainability and ingredient transparency are influencing procurement choices, prompting manufacturers to explore aqueous-based and aloe-based formulations that balance performance with environmental and safety considerations. The rise of therapeutic ultrasound applications and veterinary usages is widening the product scope, encouraging multi-purpose gel designs and packaging variants. As these dynamics play out, manufacturers and health systems are re-evaluating value propositions to meet both clinical performance requirements and the operational constraints of modern care delivery. Consequently, competitive differentiation increasingly hinges on formulation science, regulatory compliance readiness, and the agility to respond to shifting procurement criteria.

Assessment of the 2025 United States tariff implications on raw materials and supply chain configurations driving procurement and localization responses

The United States tariff environment implemented in 2025 has introduced additional complexity for manufacturers, distributors, and health systems that rely on transnational supply chains for raw materials and finished gel products. Tariff impositions on certain polymeric additives, surfactants, and packaging components have elevated input cost pressures and prompted contract renegotiations. In response, supply chain stakeholders have intensified efforts to localize sourcing, adjust safety stocks, and reassess supplier qualification processes to hedge against further policy volatility.

This policy-driven cost vector has also affected decisions around manufacturing footprint optimization, with some producers accelerating investments in domestic processing capacity to reduce exposure to cross-border levies. At the same time, distributors and institutional buyers are exploring collaborative procurement arrangements and longer-term contracting to lock in pricing and assure continuity of supply. While short-term operational impacts include higher landed costs and friction in procurement cycles, the medium-term consequence is a reconfiguration of supplier networks and an increased emphasis on supply chain transparency, dual-sourcing strategies, and regional manufacturing resilience to mitigate policy uncertainty.

In-depth segmentation insights revealing product type, viscosity, ingredient base, application and end-user dynamics that drive targeted product strategies

Segment-level analysis reveals distinct performance and adoption patterns across formulation and usage categories that shape product strategy and commercialization priorities. Based on product type, Non-Sterile Gels remain predominant in routine diagnostic imaging where cost and ease of use are prioritized, while Sterile Gels are gaining traction in interventional procedures, perioperative settings, and any context where invasive devices or compromised skin integrity heighten infection risk. Based on viscosity level, High Viscosity formulations are favored for better adherence on vertical surfaces and prolonged procedures, Medium Viscosity options strike a balance for general diagnostic use, and Low Viscosity gels are selected for applications requiring rapid probe movement or specific acoustic coupling characteristics.

Based on ingredient base, Alcohol-Based Gels offer rapid dry times and antiseptic properties for certain point-of-care contexts, Aloe-Based Gels emphasize patient comfort and natural ingredient positioning, and Aqueous-Based Gels provide predictable acoustic transmission and broad compatibility with a wide range of transducer types. Based on application, Medical Diagnostics drives large-volume demand with emphasis on image clarity and consistency, Therapeutic Ultrasound demands gels tailored for energy transmission and skin compatibility, and Veterinary Applications require robust formulations that accommodate animal anatomy and handling considerations. Based on end-user, Clinics and Diagnostic Imaging Centers often prioritize cost-effectiveness and operational convenience, Hospitals focus on sterility, regulatory compliance, and supplier reliability, and Research & Academic Institutes value customizable formulations and precise performance characteristics. These segmentation insights inform targeted product development, differentiated go-to-market approaches, and tailored regulatory strategies to meet specific clinical and operational needs.

Regional commercial and regulatory dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping sourcing, compliance, and distribution strategies

Regional dynamics are shaping sourcing approaches, regulatory alignment, and commercialization strategies across three primary geographies. In the Americas, demand patterns are influenced by a large and diverse network of hospitals and outpatient clinics that emphasize sterility standards, cost containment, and rapid adoption of point-of-care innovations, while procurement frameworks often favor consolidated supplier agreements and value-based purchasing models. In Europe, Middle East & Africa, regulatory complexity and heterogeneous reimbursement landscapes produce differentiated adoption curves, with certain markets emphasizing ingredient transparency, sustainability, and compliance with region-specific medical device directives, and emerging markets in the region presenting growth opportunities for competitively positioned manufacturers.

In the Asia-Pacific region, rapid expansion of diagnostic capacity, significant investments in healthcare infrastructure, and a growing private clinic sector drive demand for both standard diagnostic gels and specialized formulations. Supply chain strategies in this region emphasize manufacturing scale, local regulatory certification, and logistics efficiency to serve high-volume, price-sensitive channels. Across all regions, cross-border regulatory harmonization efforts, public procurement reforms, and evolving clinical guidelines contribute to the strategic calculus for product launches, regional manufacturing footprint decisions, and distributor partnerships. As stakeholders align regional commercial tactics with these dynamics, they can better navigate regulatory pathways and operational constraints to support sustainable growth and reliable supply.

Strategic competitive overview highlighting formulation differentiation, sterility validation, packaging innovation, and partnership opportunities across the industry

Competitive dynamics in the ultrasound gels sector reflect a mix of legacy manufacturers, specialty chemical formulators, and contract manufacturers that provide private-label solutions to clinical purchasers and distributors. Leading industry players are prioritizing formulation differentiation, sterility validation protocols, and packaging innovations that enhance single-use handling and reduce contamination risk. Partnerships with imaging OEMs for co-branded consumables and integrations with sterile procedural kits are emerging as strategic routes to secure recurring demand and strengthen channel relationships.

Investment in quality systems, cleanroom manufacturing, and third-party certification is becoming a core differentiator as procurement teams increasingly scrutinize supplier quality evidence and compliance records. At the same time, nimble niche players are using ingredient transparency, sustainable sourcing claims, and customer-focused service models to capture specialized segments such as veterinary channels or research institutions. For investors and corporate development teams, acquisition targets frequently include firms with unique formulation IP, regional manufacturing presence, or established distribution networks that can accelerate market entry and broaden product portfolios. Overall, the company landscape favors those who align product performance with demonstrable clinical benefits and operational reliability.

Actionable strategic recommendations focused on sterile capability expansion, portfolio modularity, supply chain diversification, and partnership-driven commercialization

Industry leaders should pursue a coordinated approach that links formulation innovation, regulatory preparedness, and supply chain resilience to maintain competitive advantage. First, prioritize investment in sterile formulation capabilities and validated packaging formats to support interventional and perioperative use cases, thereby addressing heightened infection prevention requirements and expanding into higher-value clinical segments. Next, develop a modular product portfolio that spans high, medium, and low viscosity options and leverages multiple ingredient bases to meet nuanced clinical preferences while enabling streamlined manufacturing flexibility.

In parallel, accelerate supplier diversification and regional manufacturing options to reduce exposure to policy-driven input cost shifts and to meet customers' demand for shorter lead times. Engage proactively with regulatory stakeholders to secure timely certifications and to align labeling with evolving safety and sustainability expectations. Finally, pursue selective partnerships with imaging system manufacturers and clinical service providers to embed gels into bundled offerings, creating stickier commercial relationships and clearer channels for product differentiation. Executed together, these actions will strengthen market positioning, enhance operational resilience, and create pathways to capture new clinical use cases.

Rigorous mixed-methods research methodology combining stakeholder interviews, regulatory review, and secondary evidence synthesis with quality assurance checks

This research synthesis draws on a structured approach combining primary and secondary inputs to ensure a robust and defensible evidence base. Primary inputs included interviews with clinical procurement leaders, imaging department managers, formulation scientists, and supply chain executives to surface current priorities, pain points, and operational constraints. These firsthand perspectives were complemented by a review of regulatory guidance, standards for biocompatibility and sterility, and recent clinical literature exploring ultrasound imaging and therapeutic use cases.

Secondary analysis incorporated trade publications, patent filings, formulation whitepapers, and publicly available regulatory filings to map technological innovations and competitive activity. The methodology emphasized triangulation across multiple data streams to validate trends and to contextualize strategic implications. Quality assurance protocols included cross-validation of interview findings, consistency checks against regulatory documents, and an audit trail of source materials. This layered approach ensures that conclusions are grounded in both practitioner experience and documented evidence, enabling decision-makers to apply insights with confidence in operational and clinical settings.

Concluding synthesis emphasizing the imperative of integrated strategies across formulation innovation, regulatory compliance, and supply chain resilience

In conclusion, the ultrasound gels sector is at an inflection point where formulation science, regulatory expectations, and supply chain design converge to redefine competitive advantage. Manufacturers that invest in sterile manufacturing capabilities, diversify viscosity and ingredient offerings, and strengthen regional supply resilience will be better positioned to meet evolving clinical requirements and procurement preferences. Health systems and distributors, in turn, will benefit from supplier partnerships that provide transparent quality documentation, dependable logistics, and product portfolios aligned with point-of-care and interventional workflows.

Looking ahead, success in this space will depend on the ability to translate technical formulation benefits into clear clinical and operational value propositions, to navigate regulatory pathways proactively, and to build supply chains that can withstand policy and geopolitical shifts. Stakeholders that adopt an integrated strategy-balancing innovation, compliance, and commercial agility-will be best placed to capture opportunities across diagnostic, therapeutic, and veterinary applications while maintaining the trust of clinical end users.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ultrasound Gels Market, by Product Type

  • 8.1. Non-Sterile Gels
  • 8.2. Sterile Gels

9. Ultrasound Gels Market, by Viscosity Level

  • 9.1. High Viscosity
  • 9.2. Low Viscosity
  • 9.3. Medium Viscosity

10. Ultrasound Gels Market, by Ingredient Base

  • 10.1. Alcohol-Based Gels
  • 10.2. Aloe-Based Gels
  • 10.3. Aqueous-Based Gels

11. Ultrasound Gels Market, by Application

  • 11.1. Medical Diagnostics
  • 11.2. Therapeutic Ultrasound
  • 11.3. Veterinary Applications

12. Ultrasound Gels Market, by End-User

  • 12.1. Clinics
  • 12.2. Diagnostic Imaging Centers
  • 12.3. Hospitals
  • 12.4. Research & Academic Institutes

13. Ultrasound Gels Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Ultrasound Gels Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Ultrasound Gels Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Ultrasound Gels Market

17. China Ultrasound Gels Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AiM Medical Technologies, LLC
  • 18.6. Aquasonic Ultrasound Gels Inc.
  • 18.7. Cardinal Health, Inc.
  • 18.8. Ceracarta S.p.A.
  • 18.9. Compass Health Brands
  • 18.10. EDM Medical Solutions
  • 18.11. General Electric Company
  • 18.12. HR Pharmaceuticals, Inc.
  • 18.13. Jorgensen Laboratories, LLC
  • 18.14. Medline Industries, Inc.
  • 18.15. NEXT Medical Products Company
  • 18.16. NIHON KOHDEN CORPORATION
  • 18.17. P.W. Coole & Son Ltd Trading
  • 18.18. Parker Laboratories Inc.
  • 18.19. Phyto Performance Italia srl
  • 18.20. Rohde Produits
  • 18.21. Safersonic
  • 18.22. Steroplast Healthcare Limited
  • 18.23. Telic Group
  • 18.24. Trivitron Healthcare Pvt. Ltd
  • 18.25. Turkuaz Health

LIST OF FIGURES

  • FIGURE 1. GLOBAL ULTRASOUND GELS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ULTRASOUND GELS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ULTRASOUND GELS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ULTRASOUND GELS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ULTRASOUND GELS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ULTRASOUND GELS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ULTRASOUND GELS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ULTRASOUND GELS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ULTRASOUND GELS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ULTRASOUND GELS MARKET SIZE, BY NON-STERILE GELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ULTRASOUND GELS MARKET SIZE, BY NON-STERILE GELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ULTRASOUND GELS MARKET SIZE, BY NON-STERILE GELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ULTRASOUND GELS MARKET SIZE, BY STERILE GELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ULTRASOUND GELS MARKET SIZE, BY STERILE GELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ULTRASOUND GELS MARKET SIZE, BY STERILE GELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ULTRASOUND GELS MARKET SIZE, BY HIGH VISCOSITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ULTRASOUND GELS MARKET SIZE, BY HIGH VISCOSITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ULTRASOUND GELS MARKET SIZE, BY HIGH VISCOSITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ULTRASOUND GELS MARKET SIZE, BY LOW VISCOSITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ULTRASOUND GELS MARKET SIZE, BY LOW VISCOSITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ULTRASOUND GELS MARKET SIZE, BY LOW VISCOSITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ULTRASOUND GELS MARKET SIZE, BY MEDIUM VISCOSITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ULTRASOUND GELS MARKET SIZE, BY MEDIUM VISCOSITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ULTRASOUND GELS MARKET SIZE, BY MEDIUM VISCOSITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ULTRASOUND GELS MARKET SIZE, BY ALCOHOL-BASED GELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ULTRASOUND GELS MARKET SIZE, BY ALCOHOL-BASED GELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ULTRASOUND GELS MARKET SIZE, BY ALCOHOL-BASED GELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ULTRASOUND GELS MARKET SIZE, BY ALOE-BASED GELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ULTRASOUND GELS MARKET SIZE, BY ALOE-BASED GELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ULTRASOUND GELS MARKET SIZE, BY ALOE-BASED GELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ULTRASOUND GELS MARKET SIZE, BY AQUEOUS-BASED GELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ULTRASOUND GELS MARKET SIZE, BY AQUEOUS-BASED GELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ULTRASOUND GELS MARKET SIZE, BY AQUEOUS-BASED GELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ULTRASOUND GELS MARKET SIZE, BY MEDICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ULTRASOUND GELS MARKET SIZE, BY MEDICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ULTRASOUND GELS MARKET SIZE, BY MEDICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ULTRASOUND GELS MARKET SIZE, BY THERAPEUTIC ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ULTRASOUND GELS MARKET SIZE, BY THERAPEUTIC ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ULTRASOUND GELS MARKET SIZE, BY THERAPEUTIC ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ULTRASOUND GELS MARKET SIZE, BY VETERINARY APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ULTRASOUND GELS MARKET SIZE, BY VETERINARY APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ULTRASOUND GELS MARKET SIZE, BY VETERINARY APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ULTRASOUND GELS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ULTRASOUND GELS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ULTRASOUND GELS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ULTRASOUND GELS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ULTRASOUND GELS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ULTRASOUND GELS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ULTRASOUND GELS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ULTRASOUND GELS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ULTRASOUND GELS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ULTRASOUND GELS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ULTRASOUND GELS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ULTRASOUND GELS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ULTRASOUND GELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS ULTRASOUND GELS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND GELS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ULTRASOUND GELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 108. GCC ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GCC ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. GCC ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 111. GCC ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 112. GCC ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. GCC ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 126. G7 ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. G7 ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. G7 ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 129. G7 ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 130. G7 ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. G7 ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 132. NATO ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. NATO ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NATO ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 135. NATO ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 136. NATO ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. NATO ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES ULTRASOUND GELS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA ULTRASOUND GELS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 148. CHINA ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 149. CHINA ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. CHINA ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)